5 Value Stocks In The Healthcare Sector
Portfolio Pulse from Benzinga Insights
The article identifies five value stocks in the healthcare sector based on their low price-to-earnings (P/E) multiples, suggesting they may be undervalued. The stocks mentioned are Cross Country Healthcare (CCRN), Prenetics Global (PRE), Spero Therapeutics (SPRO), Arcturus Therapeutics (ARCT), and Zymeworks (ZYME). The article also provides recent changes in earnings per share for these companies and notes the risks associated with investing in value stocks.
December 04, 2023 | 2:44 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Arcturus Therapeutics reported an improved EPS from -$1.98 to -$0.61 and has a P/E of 6.62.
The significant improvement in EPS may be viewed positively by the market, potentially leading to a short-term increase in stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Prenetics Global has an extremely low P/E of 1.0, an increase in EPS from -$0.75 to -$0.05, and a slight decrease in dividend yield.
The significant improvement in EPS could attract investors, potentially leading to a positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Spero Therapeutics has a P/E of 3.0 and an increase in EPS from -$0.23 to -$0.06.
The improvement in EPS is a positive sign that may lead to increased investor interest and a potential rise in stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Zymeworks has a P/E of 2.83 and reported an improved EPS from -$0.75 to -$0.38.
The improvement in EPS and low P/E ratio may make Zymeworks attractive to value investors, possibly driving up the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Cross Country Healthcare has a low P/E of 7.31 but experienced a decrease in EPS from $0.69 to $0.39 this quarter.
The decrease in EPS may concern investors and could negatively impact the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80